Compare Incyte Corporation (INCY) vs SoFi Technologies Inc (SOFI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Incyte Corporation vs SoFi Technologies Inc — how do they compare? Incyte Corporation trades at $112.77 (market cap $22.85B), while SoFi Technologies Inc trades at $15.75 (market cap $20.16B). The key difference: Incyte Corporation and SoFi Technologies Inc are close in size by market cap, and Incyte Corporation is trading nearer its 52-week high, SoFi Technologies Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Incyte Corporation for 33 Days and SoFi Technologies Inc for 60 Days on average.
| INCY | SOFI | |
|---|---|---|
Market Cap | $22.85B | $20.16B |
Volume | 1,927,029 | 49,646,331 |
Sector | Health | Financials |
52-Week High | $129.93 | $32.21 |
52-Week Low | $83.80 | $15.15 |
Typical Hold Time | 33 Days | 60 Days |
Enterprise Value | $18.35B | $20.30B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Incyte (INCY) trades at $113.61, up 0.15% on the day, with a mixed technical signal leaning bearish. The company reported strong 2025 results with revenue of $5.14B and net income of $1.29B, and recent earnings beats in Q1 and Q2 2026. Key developments include FDA approval for Atebrioz and a strategic focus on post-JAKAFI growth targeting $4B in non-JAKAFI sales by 2029.
The outlook is cautiously optimistic, supported by robust profitability and pipeline progress, but tempered by near-term earnings pressure and technical weakness. Risks include JAKAFI's patent expiration after 2029 and competitive threats. Analysts maintain a Buy consensus with a $132.43 price target, implying significant upside from current levels.
SoFi Technologies trades at $15.80, up 0.89% with bearish technical signals despite recent earnings beats. The company shows strong revenue growth from $2.6B in 2024 to $3.6B in 2025, though net income dipped to $481M. Analyst consensus is mixed with 37% buy ratings but a $21.58 price target suggesting 37% upside. Recent news highlights stablecoin initiatives and record loan originations amid sector volatility.
SoFi presents a growth story with expanding financial services but faces execution risks in a competitive fintech landscape. The stock's current valuation at 31.86 P/E reflects optimism about future profitability, though negative operating cash flows and rising yields create headwinds. Upside depends on sustained loan growth and successful monetization of new products like SoFiUSD.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Incyte Corporation
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Read more on INCY →About SoFi Technologies Inc
SoFi is a financial services company that was founded in 2011 and is currently based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020 the company also offers payment and account services for debit cards and digital banking.
Read more on SOFI →
